Open a free Demat account & get ₹500 in stocks.Claim
Nifty 5025,144.30.61%H 25,246.35 · L 25,054.4as of 13 Nov, 3:31 PM IST|Sensex81,592.450.39%H 81,879.51 · L 81,288.75as of 13 Nov, 3:32 PM IST|Bank Nifty61,034.10.79%H 61,300.55 · L 60,780.55as of 13 Nov, 3:31 PM IST|USD / INR₹94.240.21%H ₹94.24 · L ₹94.24as of 9:00 AM IST|Gold Intl (10g)₹1,17,750.390.03%H ₹1,18,989.61 · L ₹1,17,289.84as of 3:29 AM IST|Silver Intl (1kg)₹1,48,830.941.89%H ₹1,53,690.87 · L ₹1,46,661.54as of 3:29 AM IST|Crude WTI₹8,345.890.2%H ₹8,447.67 · L ₹8,274.27as of 3:30 AM IST|Bitcoin₹61,65,7194.49%H ₹63,04,090.36 · L ₹60,27,347.64as of 9:53 PM IST|Ethereum₹1,72,3514.85%H ₹1,76,529.95 · L ₹1,68,172.05as of 9:53 PM IST|Nifty 5025,144.30.61%H 25,246.35 · L 25,054.4as of 13 Nov, 3:31 PM IST|Sensex81,592.450.39%H 81,879.51 · L 81,288.75as of 13 Nov, 3:32 PM IST|Bank Nifty61,034.10.79%H 61,300.55 · L 60,780.55as of 13 Nov, 3:31 PM IST|USD / INR₹94.240.21%H ₹94.24 · L ₹94.24as of 9:00 AM IST|Gold Intl (10g)₹1,17,750.390.03%H ₹1,18,989.61 · L ₹1,17,289.84as of 3:29 AM IST|Silver Intl (1kg)₹1,48,830.941.89%H ₹1,53,690.87 · L ₹1,46,661.54as of 3:29 AM IST|Crude WTI₹8,345.890.2%H ₹8,447.67 · L ₹8,274.27as of 3:30 AM IST|Bitcoin₹61,65,7194.49%H ₹63,04,090.36 · L ₹60,27,347.64as of 9:53 PM IST|Ethereum₹1,72,3514.85%H ₹1,76,529.95 · L ₹1,68,172.05as of 9:53 PM IST|

Ubs

Latest news, explainers and analysis on Ubs. Tracking 5 stories on Arth Vani.

5 stories tracked

Connected in the graph

Latest on Ubs

Moderna Stock: UBS Issues Rare 'Sell' Rating, Foresees 44% Price Drop
Global Markets

Moderna Stock: UBS Issues Rare 'Sell' Rating, Foresees 44% Price Drop

Investment bank UBS has issued a rare 'sell' rating on biotech firm Moderna, projecting a significant 44% decline in its stock price. This downgrade comes despite recent investor optimism surrounding Moderna's advancements in cancer vaccines, with UBS citing concerns over the company's valuation.

70d ago·1 min readListen
UBS Buys Back Credit Suisse Bonds to Calm Markets Post-Acquisition
Banking

UBS Buys Back Credit Suisse Bonds to Calm Markets Post-Acquisition

UBS has announced plans to buy back over ₹24,960 crore ($3 billion) of Credit Suisse debt to simplify its capital structure and reduce funding costs after acquiring its rival. This move aims to boost investor confidence following the tumultuous takeover and the controversial write-down of Credit Suisse's riskiest bonds earlier this year.

106d ago·2 min readListen
UBS Updates AMD Stock Target Following Key AI Day Signals
Stock Market

UBS Updates AMD Stock Target Following Key AI Day Signals

Investment bank UBS has revised its stock price target for semiconductor giant Advanced Micro Devices (AMD), in response to signals and developments from the company's recent 'AI Day' event. This move indicates a keen analyst focus on AMD's strategies and product pipeline within the booming artificial intelligence sector, reflecting the dynamic nature of global tech markets.

109d ago·2 min readListen
BlackRock Earnings Expected: What UBS Analysts Predict for Investors
Mutual Funds

BlackRock Earnings Expected: What UBS Analysts Predict for Investors

Global investment giant BlackRock is set to release its earnings report soon. Analysts at UBS are optimistic, suggesting positive trends that could impact the broader investment landscape. Investors are keenly watching for insights into asset management performance and market outlook.

127d ago·1 min readListen
Motilal Oswal Shares Surge 5% as UBS Issues ‘Buy’ Rating on Growth Outlook
Wealth Management

Motilal Oswal Shares Surge 5% as UBS Issues ‘Buy’ Rating on Growth Outlook

Shares of Motilal Oswal Financial Services climbed on Friday following a positive outlook from global brokerage UBS. The firm highlighted India’s increasing shift toward financial assets and the company's rising recurring revenue as key growth drivers.

155d ago·1 min readListen
Wealth Management products
Compare & act on the right product for this topic
Smart picks
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
13.9%
3Y CAGR
Nippon India Small Cap Fund
Nippon India Mutual Fund · Small Cap
13.6%
3Y CAGR
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
13.0%
3Y CAGR
Axis ELSS- Tax Saver Fund
Axis Mutual Fund · ELSS
12.7%
3Y CAGR
ICICI Prudential Balanced Advantage Fund
ICICI Prudential Mutual Fund · Hybrid
12.2%
3Y CAGR
HDFC Balanced Advantage Fund
HDFC Mutual Fund · Hybrid
11.7%
3Y CAGR

Mutual fund data is sourced from AMFI and shown for information only — funds are subject to market risks. Read all scheme-related documents carefully. Some listings may be sponsored. Not investment advice.

Explore all entities in the Knowledge Graph